Skip to main content

Advertisement

SpringerLink
Log in

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Ross J, Slodkowsaka E, Symmans W et al (2009) The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 14:320–369

    Article  CAS  PubMed  Google Scholar 

  2. Verma S, Miles D, Gianni L et al for the EMILIA Study Group (2012) Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med 367:1783–1791

  3. Metro G, Foglietta J, Russillo M et al (2011) Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine. Ann Oncol 22(3):625–630

    Article  CAS  PubMed  Google Scholar 

  4. Bartsch R, Berghoff A, Preusser M (2014) Breast cancer brain metastases responding to primary systemic therapy with T-DM1. J Neurooncol 116:205–206

    Article  PubMed  Google Scholar 

  5. Torres S, Maralani P, Verma S (2014) Activity of T-DM1 in HER-2 positive central nervous system breast cancer metastases. BMJ Case Rep. doi:10.1136/bcr-2014-205680

  6. Gebhart G, Lamberts LE, Wimana Z et al (2015) Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR Trial. Ann Oncol. doi:10.1093/annonc/mdv577

Download references

Author information

Authors and Affiliations

  1. Department of Neuro-oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands

    C. L. Gorter de Vries & D. Brandsma

  2. Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

    S. C. Linn

Authors
  1. C. L. Gorter de Vries
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. C. Linn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Brandsma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Brandsma.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Vries, C.L.G., Linn, S.C. & Brandsma, D. Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1. J Neurooncol 127, 401–403 (2016). https://doi.org/10.1007/s11060-015-2045-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-015-2045-1

Keywords

Search

Navigation